Arterra Bioscience S.p.A. (BIT:ARBS)
2.840
+0.010 (0.35%)
Jun 15, 2026, 5:54 PM CET
Arterra Bioscience Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 19 | 20 | 13 | 11 | 14 | 19 | |
Market Cap Growth | 24.56% | 54.08% | 18.07% | -23.15% | -24.57% | 1.75% |
Enterprise Value | 18 | 17 | 10 | 6 | 9 | 15 |
Last Close Price | 2.84 | 2.87 | 1.76 | 1.42 | 1.77 | 2.32 |
PE Ratio | 9.43 | 10.02 | 9.76 | 10.27 | 10.17 | 17.17 |
PS Ratio | 4.02 | 4.27 | 3.13 | 3.31 | 4.01 | 4.02 |
PB Ratio | 1.50 | 1.60 | 1.14 | 1.03 | 1.37 | 2.01 |
P/TBV Ratio | 1.51 | 1.60 | 1.15 | 1.03 | 1.38 | 2.04 |
P/FCF Ratio | 12.29 | 13.07 | 30.81 | 11.52 | 11.06 | 22.28 |
P/OCF Ratio | 9.49 | 10.09 | 12.26 | 10.77 | 10.31 | 13.65 |
EV/Sales Ratio | 3.79 | 3.64 | 2.39 | 1.67 | 2.64 | 3.20 |
EV/EBITDA Ratio | 8.02 | 7.71 | 5.82 | 3.50 | 4.44 | 8.74 |
EV/EBIT Ratio | 9.23 | 8.86 | 7.26 | 5.26 | 5.91 | 12.16 |
EV/FCF Ratio | 11.58 | 11.13 | 23.53 | 5.80 | 7.27 | 17.73 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.03 | 0.04 | 0.05 | 0.07 |
Debt / EBITDA Ratio | 0.12 | 0.12 | 0.21 | 0.24 | 0.23 | 0.35 |
Debt / FCF Ratio | 0.17 | 0.17 | 0.84 | 0.40 | 0.38 | 0.72 |
Net Debt / Equity Ratio | -0.09 | -0.09 | -0.26 | -0.31 | -0.53 | -0.44 |
Net Debt / EBITDA Ratio | -0.49 | -0.49 | -1.74 | -2.07 | -2.58 | -2.42 |
Net Debt / FCF Ratio | -0.70 | -0.70 | -7.05 | -3.44 | -4.23 | -4.91 |
Asset Turnover | 0.34 | 0.34 | 0.32 | 0.27 | 0.30 | 0.43 |
Inventory Turnover | 1.23 | 1.23 | 1.31 | 1.18 | 1.40 | 2.72 |
Quick Ratio | 6.02 | 6.02 | 8.44 | 7.74 | 7.48 | 6.51 |
Current Ratio | 7.80 | 7.80 | 10.06 | 9.35 | 8.49 | 6.91 |
Return on Equity (ROE) | 16.72% | 16.72% | 12.06% | 10.14% | 14.18% | 12.58% |
Return on Assets (ROA) | 8.63% | 8.63% | 6.61% | 5.27% | 8.29% | 7.12% |
Return on Invested Capital (ROIC) | 19.38% | 19.38% | 13.58% | 14.10% | 24.60% | 22.37% |
Return on Capital Employed (ROCE) | 14.10% | 14.10% | 10.90% | 9.00% | 14.00% | 12.10% |
Earnings Yield | 10.61% | 9.98% | 10.24% | 9.74% | 9.83% | 5.83% |
FCF Yield | 8.14% | 7.65% | 3.25% | 8.69% | 9.05% | 4.49% |
Dividend Yield | 4.58% | - | 7.38% | 7.05% | 5.66% | 2.15% |
Payout Ratio | 42.20% | 42.20% | 49.81% | 61.87% | - | - |
Total Shareholder Return | 4.58% | - | 7.38% | 7.05% | 5.66% | 2.15% |